相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
Donato Iacovazzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion
Cuiqi Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
I. Tuominen et al.
ONCOGENE (2015)
Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth
Takashi Nomiyama et al.
DIABETES (2014)
A Novel C-terminal Nonsense Mutation, Q315X, of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in a Japanese Familial Isolated Pituitary Adenoma Family
Takeo Iwata et al.
ENDOCRINE PATHOLOGY (2014)
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
Albert Beckers et al.
ENDOCRINE REVIEWS (2013)
Aip regulates cAMP signalling and GH secretion in GH3 cells
R. Formosa et al.
ENDOCRINE-RELATED CANCER (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 Patients
Laure Cazabat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
Harvinder S. Chahal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition
Rhodri M. L. Morgan et al.
PLOS ONE (2012)
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas
Maria A. Tichomirowa et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
Sandrine Fieffe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Mice with Inactivation of Aryl Hydrocarbon Receptor-Interacting Protein (Aip) Display Complete Penetrance of Pituitary Adenomas with Aberrant ARNT Expression
Anniina Raitila et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
ZAC1 target genes and pituitary tumorigenesis
Marily Theodoropoulou et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Inhibition of 5α-Reductase Enhances Testosterone-Induced Expression of U19/Eaf2 Tumor Suppressor During the Regrowth of LNCaP Xenograft Tumor in Nude Mice
Shubham Gupta et al.
PROSTATE (2010)
Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)
Harvinder S. Chahal et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?
Bharat B. Aggarwal et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
Marie-Lise Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2009)
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly
Marily Theodoropoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Acromegaly pathogenesis and treatment
Shlomo Melmed
JOURNAL OF CLINICAL INVESTIGATION (2009)
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas
Chrysanthia A. Leontiou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell line
Simona Grozinsky-Glasberg et al.
NEUROENDOCRINOLOGY (2008)
Steroidogenic factor 1/adrenal 4 binding protein transforms human bone marrow mesenchymal cells into steroidogenic cells
Tomoko Tanaka et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2007)
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas:: Analysis in 73 families
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Pituitary adenoma predisposition caused by germline mutations in the AIP gene
Outi Vierimaa et al.
SCIENCE (2006)
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression
M Theodoropoulou et al.
CANCER RESEARCH (2006)
Does growth hormone cause cancer?
PJ Jenkins et al.
CLINICAL ENDOCRINOLOGY (2006)
Multiple regulation of adenylyl cyclase activity by G-protein coupled receptors in human foetal lung fibroblasts
R Busto et al.
REGULATORY PEPTIDES (2000)
分享论文
